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They showed that the ante situm liver resection can be safely performed in an experienced HPB center without hypothermia and veno-venous bypass [1] . However, we have some questions and comments:
Since we see an indication for the hypothermic perfusion to increase the ischemic tolerance in these long procedures, we are interested in the postoperative liver function tests in the described cohort.
In addition, we see the avoidance of the veno-venous bypass quite critically, taking into account the largest publication so far by Azoulay et al., which showed a 90-day mortality of 19.5% in 77 patients treated with in situ hypothermic perfusion and bypass [2] .
Reflected by the data of the present study, only 2 of 8 patients received a complete inferior vena cava (IVC)-replacement. According to our data of 12 consecutive cases of either ante situm or in situ resections with bypass and hypothermia, we did not experience any mortality. Thus, we firmly believe that the time-consuming phase, which may pose difficulties for the surgeon, arises not during the resection, but during the reconstruction of the IVC and the venous outflow. The abandoned techniques might alleviate this time pressure.
Furthermore, the statement B…preferred to be prepared to initiate cold perfusion...^remains unclear and we would like to know your concrete indications for starting a cold perfusion during the ongoing procedure. In our hands, we prefer to start with cold perfusion/bypass in all patients eligible for an ante situm resection with expected reconstruction of the IVC and venous outflow in order to increase safety.
Finally, we agree that not all in situ operations need to be performed with veno-venous bypass, since a reconstruction of the IVC and/or the ante situm position are not always necessary. We would like to ask the authors to balance the possible side effects of the bypass and/or cold perfusion with the 19.5% liver insufficiency rate reported by Azoulay et al. [2] .
We thank the Hanover group for their outstanding paper and the initiation of this very interesting discussion.
